Bank of New York Mellon’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.63M | Sell |
148,627
-137
| -0.1% | -$6.5K | ﹤0.01% | 2274 |
|
|
2026
Q1 | $7.67M | Sell |
148,764
-67,016
| -31% | -$4.69M | ﹤0.01% | 2068 |
|
|
2025
Q4 | $19.9M | Buy |
215,780
+48,904
| +29% | +$4.68M | ﹤0.01% | 1543 |
|
|
2025
Q3 | $12.4M | Sell |
166,876
-160,877
| -49% | -$16.3M | ﹤0.01% | 1813 |
|
|
2025
Q2 | $42.5M | Sell |
327,753
-52,507
| -14% | -$7.61M | 0.01% | 1104 |
|
|
2025
Q1 | $60.6M | Sell |
380,260
-200,611
| -35% | -$36.3M | 0.01% | 843 |
|
|
2024
Q4 | $108M | Sell |
580,871
-191,894
| -25% | -$37.2M | 0.02% | 612 |
|
|
2024
Q3 | $163M | Sell |
772,765
-15,050
| -2% | -$2.61M | 0.03% | 438 |
|
|
2024
Q2 | $105M | Buy |
787,815
+192,238
| +32% | +$36.4M | 0.02% | 614 |
|
|
2024
Q1 | $128M | Buy |
595,577
+197,097
| +49% | +$38.6M | 0.02% | 545 |
|
|
2023
Q4 | $81.1M | Buy |
398,480
+24,686
| +7% | +$4M | 0.02% | 755 |
|
|
2023
Q3 | $74.2M | Buy |
373,794
+128,078
| +52% | +$32.3M | 0.02% | 773 |
|
|
2023
Q2 | $79.8M | Sell |
245,716
-28,329
| -10% | -$8.09M | 0.02% | 745 |
|
|
2023
Q1 | $64.1M | Sell |
274,045
-4,301
| -2% | -$1.09M | 0.01% | 860 |
|
|
2022
Q4 | $70.1M | Sell |
278,346
-13,779
| -5% | -$2.94M | 0.02% | 778 |
|
|
2022
Q3 | $51.8M | Buy |
292,125
+6,784
| +2% | +$1.36M | 0.01% | 933 |
|
|
2022
Q2 | $52.1M | Buy |
285,341
+34,977
| +14% | +$6.98M | 0.01% | 951 |
|
|
2022
Q1 | $64.3M | Buy |
250,364
+126,452
| +102% | +$28.9M | 0.01% | 931 |
|
|
2021
Q4 | $28.5M | Sell |
123,912
-3,618
| -3% | -$883K | 0.01% | 1512 |
|
|
2021
Q3 | $29.7M | Buy |
127,530
+10,514
| +9% | +$2.19M | 0.01% | 1483 |
|
|
2021
Q2 | $22.6M | Buy |
117,016
+695
| +0.6% | +$138K | ﹤0.01% | 1670 |
|
|
2021
Q1 | $24.1M | Sell |
116,321
-4,801
| -4% | -$1.02M | ﹤0.01% | 1602 |
|
|
2020
Q4 | $22.8M | Buy |
121,122
+2,636
| +2% | +$431K | 0.01% | 1567 |
|
|
2020
Q3 | $15.3M | Buy |
118,486
+3,951
| +3% | +$435K | ﹤0.01% | 1629 |
|
|
2020
Q2 | $9.97M | Buy |
114,535
+37,538
| +49% | +$2.89M | ﹤0.01% | 1843 |
|
|
2020
Q1 | $4.64M | Sell |
76,997
-167
| -0.2% | -$12.4K | ﹤0.01% | 2108 |
|
|
2019
Q4 | $5.73M | Buy |
77,164
+3,656
| +5% | +$235K | ﹤0.01% | 2268 |
|
|
2019
Q3 | $4.48M | Buy |
73,508
+6,606
| +10% | +$435K | ﹤0.01% | 2335 |
|
|
2019
Q2 | $4.06M | Buy |
66,902
+2,488
| +4% | +$134K | ﹤0.01% | 2437 |
|
|
2019
Q1 | $3.66M | Buy |
64,414
+202
| +0.3% | +$10.9K | ﹤0.01% | 2481 |
|
|
2018
Q4 | $2.71M | Buy |
64,212
+10,786
| +20% | +$459K | ﹤0.01% | 2594 |
|
|
2018
Q3 | $2.25M | Buy |
53,426
+101
| +0.2% | +$4.74K | ﹤0.01% | 2783 |
|
|
2018
Q2 | $1.9M | Buy |
+53,325
| New | +$1.72M | ﹤0.01% | 2877 |
|
Other funds holding INSP
AIMCA
RCW
Bank of New York Mellon's INSP Position: Q2 2026 in Review
Bank of New York Mellon reduced its Inspire Medical Systems (INSP) stake by 0.09% in Q2 2026, selling an estimated $6.5K and leaving 148,627 shares worth $6.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2274.
Bank of New York Mellon first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $163M in Q3 2024. 106 funds tracked by Wall St. Rank hold INSP as of Q2 2026.
- Bank of New York Mellon held 148,627 shares of Inspire Medical Systems worth $6.63M as of Q2 2026.
- Bank of New York Mellon sold 137 Inspire Medical Systems shares in Q2 2026, an estimated $6.5K.
- Inspire Medical Systems made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2274 holding.
- Bank of New York Mellon first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
- Bank of New York Mellon's Inspire Medical Systems position peaked at $163M in Q3 2024.
- 106 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.